Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

BJ Druker; F Guilhot; SG O'Brien; I Gathmann; H Kantarjian; N Gattermann; MWN Deininger; RT Silver; JM Goldman; RM Stone; F Cervantes; A Hochhaus; BL Powell; JL Gabrilove; P Rousselot; J Reiffers; Jan Cornelissen; T Hughes; H Agis; T Fischer; G Verhoef; J Shepherd; G Saglio; A Gratwohl; JL Nielsen; JP Radich; B Simonsson; K Taylor; M Baccarani; C So; L Letvak; RA Larson

doi:10.1056/NEJMoa062867

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

BJ Druker, F Guilhot, SG O'Brien, I Gathmann, H Kantarjian, N Gattermann, MWN Deininger, RT Silver, JM Goldman, RM Stone, F Cervantes, A Hochhaus, BL Powell, JL Gabrilove, P Rousselot, J Reiffers, Jan Cornelissen, T Hughes, H Agis, T FischerG Verhoef, J Shepherd, G Saglio, A Gratwohl, JL Nielsen, JP Radich, B Simonsson, K Taylor, M Baccarani, C So, L Letvak, RA Larson

Research output: Contribution to journal › Article › Academic › peer-review

3070 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2408-2417
Number of pages	10
Journal	New England Journal of Medicine
Volume	355
Issue number	23
DOIs	https://doi.org/10.1056/NEJMoa062867
Publication status	Published - 2006

Research programs

EMC MM-02-41-03

Access to Document

10.1056/NEJMoa062867

http://hdl.handle.net/1765/62179

Cite this

Druker, BJ., Guilhot, F., O'Brien, SG., Gathmann, I., Kantarjian, H., Gattermann, N., Deininger, MWN., Silver, RT., Goldman, JM., Stone, RM., Cervantes, F., Hochhaus, A., Powell, BL., Gabrilove, JL., Rousselot, P., Reiffers, J., Cornelissen, J., Hughes, T., Agis, H., ... Larson, RA. (2006). Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. New England Journal of Medicine, 355(23), 2408-2417. https://doi.org/10.1056/NEJMoa062867

@article{d9600a5fb41a4f109bdfdc2589973071,

title = "Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia",

author = "BJ Druker and F Guilhot and SG O'Brien and I Gathmann and H Kantarjian and N Gattermann and MWN Deininger and RT Silver and JM Goldman and RM Stone and F Cervantes and A Hochhaus and BL Powell and JL Gabrilove and P Rousselot and J Reiffers and Jan Cornelissen and T Hughes and H Agis and T Fischer and G Verhoef and J Shepherd and G Saglio and A Gratwohl and JL Nielsen and JP Radich and B Simonsson and K Taylor and M Baccarani and C So and L Letvak and RA Larson",

year = "2006",

doi = "10.1056/NEJMoa062867",

language = "Undefined/Unknown",

volume = "355",

pages = "2408--2417",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "23",

}

Druker, BJ, Guilhot, F, O'Brien, SG, Gathmann, I, Kantarjian, H, Gattermann, N, Deininger, MWN, Silver, RT, Goldman, JM, Stone, RM, Cervantes, F, Hochhaus, A, Powell, BL, Gabrilove, JL, Rousselot, P, Reiffers, J, Cornelissen, J, Hughes, T, Agis, H, Fischer, T, Verhoef, G, Shepherd, J, Saglio, G, Gratwohl, A, Nielsen, JL, Radich, JP, Simonsson, B, Taylor, K, Baccarani, M, So, C, Letvak, L & Larson, RA 2006, 'Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia', New England Journal of Medicine, vol. 355, no. 23, pp. 2408-2417. https://doi.org/10.1056/NEJMoa062867

TY - JOUR

T1 - Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

AU - Druker, BJ

AU - Guilhot, F

AU - O'Brien, SG

AU - Gathmann, I

AU - Kantarjian, H

AU - Gattermann, N

AU - Deininger, MWN

AU - Silver, RT

AU - Goldman, JM

AU - Stone, RM

AU - Cervantes, F

AU - Hochhaus, A

AU - Powell, BL

AU - Gabrilove, JL

AU - Rousselot, P

AU - Reiffers, J

AU - Cornelissen, Jan

AU - Hughes, T

AU - Agis, H

AU - Fischer, T

AU - Verhoef, G

AU - Shepherd, J

AU - Saglio, G

AU - Gratwohl, A

AU - Nielsen, JL

AU - Radich, JP

AU - Simonsson, B

AU - Taylor, K

AU - Baccarani, M

AU - So, C

AU - Letvak, L

AU - Larson, RA

PY - 2006

Y1 - 2006

U2 - 10.1056/NEJMoa062867

DO - 10.1056/NEJMoa062867

M3 - Article

C2 - 17151364

SN - 0028-4793

VL - 355

SP - 2408

EP - 2417

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 23

ER -